Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.

Calvez T, Chambost H, d'Oiron R, Dalibard V, Demiguel V, Doncarli A, Gruel Y, Huguenin Y, Lutz P, Rothschild C, Vinciguerra C, Goudemand J; for FranceCoag Collaborators.

Haematologica. 2018 Jan;103(1):179-189. doi: 10.3324/haematol.2017.174706. Epub 2017 Oct 12.

2.

Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit.

Meunier S, Chambost H, Demiguel V, Doncarli A, Suzan F, Trossaƫrt M.

J Pediatr. 2013 Jun;162(6):1241-4, 1244.e1. doi: 10.1016/j.jpeds.2012.11.080. Epub 2013 Jan 17.

PMID:
23333129
3.

Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort.

Chambost H, Doncarli A, Bertrand MA, Briquel ME, Gay V, Pincemaille O, Trossaert M, Calvez T; for FranceCoag Network group.

Haemophilia. 2007 Nov;13(6):712-21.

PMID:
17973847
4.

A recurrent valpha17/vbeta10 TCR-expressing T cell clone is involved in the pathogenicity of collagen-induced arthritis in DBA/1 mice.

Doncarli A, Chiocchia G, Stasiuk LM, Herbage D, Boutillon MM, Fournier C, Abehsira-Amar O.

Eur J Immunol. 1999 Nov;29(11):3636-42.

PMID:
10556819
5.

Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.

Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O.

Eur J Immunol. 1997 Jun;27(6):1451-8.

PMID:
9209498

Supplemental Content

Loading ...
Support Center